Literature DB >> 18442859

Use of Complementary and Alternative Medicine among adult patients for depression in Taiwan.

Mei-Chi Hsu1, Debra Creedy, Wendy Moyle, Lorraine Venturato, Shiow-Luan Tsay, Wen-Chen Ouyang.   

Abstract

BACKGROUND: This descriptive exploratory study investigated the prevalence and type of Complementary and Alternative Medicine (CAM) use among older Taiwanese patients with a diagnosis of depression.
METHOD: Self-report questionnaire.
RESULTS: A convenience sample of 206 in-patients (98% response rate) completed the survey. Nearly 70% (69.9%) reported using at least one form of CAM in the past 12 months. Twenty-one kinds of CAM were identified in the treatment of depression, the most common being herbal medicines, spiritual healing, and folk remedies. Only one-third (35.4%, n=73) had discussed CAM use with their psychiatrists. Participants with mild to moderate depression tended to use more CAM than participants with severe depression (GDS-SF: Cramer's V=-.233; HDRS: Cramer's V=.201).
CONCLUSIONS: This study confirms the high prevalence of CAM use among older adults with a diagnosis of depression in Taiwan. The popularity of CAM appears to be a consequence of people's preference for a more holistic approach to health care. CAM use needs to be explicitly discussed between patients and health professionals as part of ongoing assessment, patient education and management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18442859     DOI: 10.1016/j.jad.2008.03.010

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  8 in total

1.  Proteomic Analysis of the Antidepressant Effects of Shen-Zhi-Ling in Depressed Patients: Identification of Proteins Associated with Platelet Activation and Lipid Metabolism.

Authors:  Chao Chen; Yuan Hu; Xian-Zhe Dong; Xiao-Jiang Zhou; Li-Hua Mu; Ping Liu
Journal:  Cell Mol Neurobiol       Date:  2018-03-21       Impact factor: 5.046

2.  Use of Complementary and Alternative Medicine among People with Type 2 Diabetes in Taiwan: A Cross-Sectional Survey.

Authors:  Hsiao-Yun Annie Chang; Marianne Wallis; Evelin Tiralongo
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-08       Impact factor: 2.629

Review 3.  Prescription of Chinese Herbal Medicine in Pattern-Based Traditional Chinese Medicine Treatment for Depression: A Systematic Review.

Authors:  Wing-Fai Yeung; Ka-Fai Chung; Ka-Yan Ng; Yee-Man Yu; Shi-Ping Zhang; Bacon Fung-Leung Ng; Eric Tat-Chi Ziea
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-09       Impact factor: 2.629

Review 4.  The chiropractic profession: a scoping review of utilization rates, reasons for seeking care, patient profiles, and care provided.

Authors:  Peter J H Beliveau; Jessica J Wong; Deborah A Sutton; Nir Ben Simon; André E Bussières; Silvano A Mior; Simon D French
Journal:  Chiropr Man Therap       Date:  2017-11-22

5.  Ziziphi spinosae lily powder suspension in the treatment of depression-like behaviors in rats.

Authors:  Yifang Wang; Mei Huang; Xinyi Lu; Runze Wei; Jinyong Xu
Journal:  BMC Complement Altern Med       Date:  2017-04-28       Impact factor: 3.659

6.  Combination of 3-Dimensional Virtual Reality and Hands-On Aromatherapy in Improving Institutionalized Older Adults' Psychological Health: Quasi-Experimental Study.

Authors:  Jong-Long Guo; Vivian Ya-Wen Cheng; Chiu-Mieh Huang; Jung-Yu Liao; Hsiao-Pei Hsu; Shih-Wen Wang; Su-Fei Huang
Journal:  J Med Internet Res       Date:  2020-07-23       Impact factor: 5.428

7.  Factors associated with the use of complementary therapies in Taiwanese patients with systemic lupus erythematosus: a cross-sectional study.

Authors:  Ming-Chi Lu; Hui-Chin Lo; Hsiu-Hua Chang; Chia-Wen Hsu; Malcolm Koo
Journal:  BMC Complement Med Ther       Date:  2021-10-01

Review 8.  Herbal Medicine for Anxiety, Depression and Insomnia.

Authors:  Lei Liu; Changhong Liu; Yicun Wang; Pu Wang; Yuxin Li; Bingjin Li
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.